Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice

Yoshiaki Kanaya, Hiroyoshi Doihara, Kouji Shiroma, Yutaka Ogasawara, Hiroshi Date

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose. We evaluated the effects of combined treatment with the antiestrogen agent toremifene (TOR) and local hyperthermia (LHT) on the MCF-7 breast cancer cell line. Methods. BALB/c mice implanted with MCF-7 cells were divided into six treatment groups: a control group, a TOR30 group (given 30 mg/kg/day), a TOR120 group (given 120 mg/kg/day), an LHT group (43.5°C), a TOR30 + LHT group, and a TOR120 + LHT group. The effects of the treatments on tumor cells, estrogen receptor (ER) expression, and cell cycle kinetics were measured after 21 days. We calculated the apoptotic index and vascular density inside the tumors and evaluated the efficacy of the transmigration of TOR into the tumors. Results. The antitumor effects were significantly greater in both combined therapy groups than in any of the single therapy groups. Estrogen receptor expression was weaker in the combined therapy groups than in the single therapy groups, and there were more G0/G1-phase cells and fewer S-phase cells in both combined therapy groups than in the single therapy groups. The apoptotic index was increased and the tumor vascular density was decreased in the combined therapy groups. Conclusions. We attributed the effects of this combined therapy to the induction of apoptosis, the decrease in vascular density, and the increase and decrease in G0/G1-phase and S-phase cells, respectively, in the tumors.

Original languageEnglish
Pages (from-to)911-920
Number of pages10
JournalSurgery today
Volume38
Issue number10
DOIs
Publication statusPublished - Oct 2008

Keywords

  • Angiogenesis
  • Apoptosis
  • Breast cancer
  • Hyperthermia
  • Toremifene

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice'. Together they form a unique fingerprint.

  • Cite this